Logo image of ALAGP.PA

AGRIPOWER FRANCE SA (ALAGP.PA) Stock Fundamental Analysis

EPA:ALAGP - Euronext Paris - Matif - FR0013452281 - Common Stock - Currency: EUR

1.155  -0.04 (-3.35%)

Fundamental Rating

3

ALAGP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 107 industry peers in the Machinery industry. While ALAGP seems to be doing ok healthwise, there are quite some concerns on its profitability. ALAGP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALAGP had negative earnings in the past year.
In the past year ALAGP has reported a negative cash flow from operations.
In multiple years ALAGP reported negative net income over the last 5 years.
ALAGP had a negative operating cash flow in each of the past 5 years.
ALAGP.PA Yearly Net Income VS EBIT VS OCF VS FCFALAGP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

ALAGP's Return On Assets of -36.44% is on the low side compared to the rest of the industry. ALAGP is outperformed by 90.65% of its industry peers.
ALAGP's Return On Equity of -68.85% is on the low side compared to the rest of the industry. ALAGP is outperformed by 87.85% of its industry peers.
Industry RankSector Rank
ROA -36.44%
ROE -68.85%
ROIC N/A
ROA(3y)-15.07%
ROA(5y)-8.88%
ROE(3y)-28.44%
ROE(5y)-16.79%
ROIC(3y)N/A
ROIC(5y)N/A
ALAGP.PA Yearly ROA, ROE, ROICALAGP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

ALAGP's Gross Margin of 21.83% is on the low side compared to the rest of the industry. ALAGP is outperformed by 81.31% of its industry peers.
ALAGP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALAGP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.88%
GM growth 5Y-25.72%
ALAGP.PA Yearly Profit, Operating, Gross MarginsALAGP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

4

2. Health

2.1 Basic Checks

ALAGP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALAGP has more shares outstanding
Compared to 5 years ago, ALAGP has more shares outstanding
The debt/assets ratio for ALAGP is higher compared to a year ago.
ALAGP.PA Yearly Shares OutstandingALAGP.PA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALAGP.PA Yearly Total Debt VS Total AssetsALAGP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

ALAGP has an Altman-Z score of -0.79. This is a bad value and indicates that ALAGP is not financially healthy and even has some risk of bankruptcy.
ALAGP has a worse Altman-Z score (-0.79) than 77.57% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that ALAGP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.30, ALAGP is in line with its industry, outperforming 53.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z -0.79
ROIC/WACCN/A
WACC6.72%
ALAGP.PA Yearly LT Debt VS Equity VS FCFALAGP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 3.74 indicates that ALAGP has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.74, ALAGP belongs to the best of the industry, outperforming 92.52% of the companies in the same industry.
ALAGP has a Quick Ratio of 3.52. This indicates that ALAGP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.52, ALAGP belongs to the best of the industry, outperforming 93.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.74
Quick Ratio 3.52
ALAGP.PA Yearly Current Assets VS Current LiabilitesALAGP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

ALAGP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -117.70%.
ALAGP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -76.93%.
ALAGP shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -28.23% yearly.
EPS 1Y (TTM)-117.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.94%
Revenue 1Y (TTM)-76.93%
Revenue growth 3Y-45.36%
Revenue growth 5Y-28.23%
Sales Q2Q%-68.25%

3.2 Future

The Earnings Per Share is expected to grow by 106.83% on average over the next years. This is a very strong growth
ALAGP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 36.73% yearly.
EPS Next Y166.67%
EPS Next 2Y106.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.83%
Revenue Next 2Y36.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALAGP.PA Yearly Revenue VS EstimatesALAGP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B 10B
ALAGP.PA Yearly EPS VS EstimatesALAGP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALAGP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 9.34, the valuation of ALAGP can be described as reasonable.
ALAGP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALAGP is cheaper than 79.44% of the companies in the same industry.
ALAGP is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 9.34
ALAGP.PA Price Earnings VS Forward Price EarningsALAGP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALAGP.PA Per share dataALAGP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALAGP's earnings are expected to grow with 106.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y106.83%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALAGP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGRIPOWER FRANCE SA

EPA:ALAGP (7/18/2025, 7:00:00 PM)

1.155

-0.04 (-3.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-27 2025-03-27
Earnings (Next)10-08 2025-10-08
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.39%
Ins Owner ChangeN/A
Market Cap4.16M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.34
P/S 3.02
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 0.62
EV/EBITDA N/A
EPS(TTM)-1.37
EYN/A
EPS(NY)0.12
Fwd EY10.7%
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.38
BVpS1.97
TBVpS1.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.44%
ROE -68.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.83%
FCFM N/A
ROA(3y)-15.07%
ROA(5y)-8.88%
ROE(3y)-28.44%
ROE(5y)-16.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.88%
GM growth 5Y-25.72%
F-Score1
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 875.43%
Cap/Sales 11.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.74
Quick Ratio 3.52
Altman-Z -0.79
F-Score1
WACC6.72%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.94%
EPS Next Y166.67%
EPS Next 2Y106.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-76.93%
Revenue growth 3Y-45.36%
Revenue growth 5Y-28.23%
Sales Q2Q%-68.25%
Revenue Next Year20.83%
Revenue Next 2Y36.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year183.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y67.84%
OCF growth 3YN/A
OCF growth 5YN/A